Effects of panitumumab on the proteome of treated EGFRvIII glioblastoma cells and on their extracellular vesicles
Amy Gateau, Baptiste Moeglen-Paget, Stéphanie Durand, Hussein Akil, Georges Humbert, Barbara Bessette, Fabrice Lalloué
This study examines how panitumumab affects the proteome of EGFRvIII glioblastoma cells and their extracellular vesicles, showing reduced EGFRvIII on EVs and changes in extracellular matrix proteins.
bioRxiv · Oct 25, 2026 · PreprintCancer Biology